1M6MYTD1Y5YMAX
Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | Dec 2025 | |
|---|---|---|
| Revenue | −85.01k | - |
| Gross profit | −191.69k | - |
| Net profit | 3.04m | - |
| EBITDA | 3.24m | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | 12.91m€ |
Number of shares | 1.30m |
52-week high/low | 9,98€ - 7,18€ |
Dividend yield | 7,87% |
Dividends TTM | 0,77€ |
Next dividend | 0,0637€ |
Beta | 0,69 |
P/E ratio | 4,44 |
PEG ratio | −0,01 |
P/B ratio | 1,07 |
P/S ratio | −20,17 |
Company profile
Big Pharma Split Corp ist ein geschlossener Aktienfonds, der von Harvest Portfolios Group Inc. aufgelegt und verwaltet wird. Er investiert in die öffentlichen Aktienmärkte der Vereinigten Staaten. Der Fonds investiert hauptsächlich in den Pharmasektor. Big Pharma Split Corp wurde am 15. September 2017 aufgelegt und hat seinen Sitz in Kanada.
| Name | BIG PHARMA SPLIT CL.A Aktie |
| CEO | Louis Michael Kovacs |
| Headquarters | Oakville,
on Canada |
| Website | |
| IPO | 11/27/2017 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Toronto Stock Exchange | PRM.TO |
Discover assets
Shareholders of BIG PHARMA SPLIT CL.A Aktie also invest in the following assets
